INS and Alzheimer disease: Among patients who received insulin alone, patients with a higher cDDD of insulin had a higher risk of developing AD than those with a lower cDDD of insulin (aHR = 1.279, 1.288 and 1.530 for cDDD < 258, 258–713 and ≧ 714, respectively; all p < 0.05, Table 3).